98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878027 | PMC |
http://dx.doi.org/10.1111/all.15492 | DOI Listing |
Ann Neurosci
August 2025
School of Pharmaceutical and Population Health Informatics, DIT University, Dehradun, Uttarakhand, India.
Background: Memory, learning, language and decision-making are just some of the cognitive abilities that may be negatively impacted by neurological illnesses such as dementia, anxiety and depression.
Purpose: This research aims to examine the influence of demographic variables on the prevalence of dementia, anxiety and depression in patients recovering from COVID-19.
Methods: This research looks at those who are at risk of developing dementia, anxiety or depression after being exposed to COVID-19.
Expert Rev Vaccines
August 2025
Pfizer Inc, New York, NY, USA.
Am J Respir Crit Care Med
August 2025
Columbia University Irving Medical Center, Medicine, New York, New York, United States.
Muscle Nerve
August 2025
Department of Neurology, Nippon Medical School, Tokyo, Japan.
Oral Dis
August 2025
Department of Dental Basic Education, Asahi University School of Dentistry, Mizuho, Japan.